• The financing was co-led by existing investor Sofinnova Ventures and new investor Redmile Group. (fenwick.com)
  • Existing investors OrbiMed, 5AM Ventures, Versant Ventures, Deerfield Management Company and Venrock also participated. (fenwick.com)
  • Before joining Canvas, Narasin worked an institutional seed investor, specifically as President, Seed Stage Investments and oversees seed funding investment activities at TriplePoint Ventures where he made investments in approximately 75 companies over eight years. (vator.tv)
  • A total of 448 investors participated in the mHealth category in 2020, led by Khosla Ventures and Techstars with five rounds each, followed by Optum Ventures and Y Combinator with four each. (mercomcapital.com)
  • DispatchHealth , a home healthcare services app, closed a $135.8 million Series C round, led by Optum Ventures, with participation from existing investors Alta Partners, Questa Capital, Echo Health Ventures, new investors Oak HC/FT, Humana, and additional strategic investors. (mercomcapital.com)
  • Strava , a GPS based tracking app for cyclers and runners, raised $110 million in funding, led by TCV and Sequoia Capital, with participation by Dragoneer Investment Group and existing investors including Madrone Capital Partners, Jackson Square Ventures, and Go4it Capital. (mercomcapital.com)
  • Whether you're a startup seeking capital and exposure, or an investor seeking new deals, Venture Summit Virtual Connect presented by youngStartup Ventures - is the event of the year you won't want to miss. (advanceventures.com)
  • Last December, the company raised $74.5 million in a series B round led by OrbiMed, rounding out its collection of investors with Nextech Invest, Vida Ventures, and Eshelman Ventures. (precisionmedicineonline.com)
  • Existing investors Foresite Capital, OrbiMed, Nextech Invest, and Vida Ventures also participated in the round. (kinnate.com)
  • The financing was led by Patient Square Capital, with participation from new investors Woodline Partners LP, CAM Capital, Hongkou, Alumni Ventures and others. (patientsquarecapital.com)
  • All existing institutional investors also participated in this round, including QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Transhuman Capital, Narya Capital, Amplo and the Juvenile Diabetes Research Foundation T1D Fund. (patientsquarecapital.com)
  • New investors participating in the round include funds and accounts managed by BlackRock, The Chernin Group (TCG), Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures, and Portfolia, as well as existing investors Goodwater Capital, Highland Capital Partners, and Next Coast Ventures. (femtechinsider.com)
  • The 2021 RealLIST Startups honoree's Series B was led by DFJ Growth with participation from Eli Lilly and Co., Point72, Brown Advisory, Point Field Partners, Initiate Ventures, Open Field Capital and PTX Capital. (mdtechcouncil.com)
  • The round also included previous investors from the company's $100 million raise last year like Cowen Healthcare Investments, Foresite Capital, Menlo Ventures, OrbiMed, Samsara BioCapital, Rock Springs Capital, Northpond Ventures, AV8 Ventures, Illumina Ventures, Windham Venture Partners and funds and accounts advised by T. Rowe Price. (mdtechcouncil.com)
  • The round, technically a Series G, is being co-led by Perceptive Advisors and Northpond Ventures (both specialist science and biotech investors), with participation also from previous backers GV (which has been around since almost the beginning), Foresite Capital, TPG Capital and First Round Capital. (automatic.pk)
  • As of March 2021, the company had raised four funds: Foresite Capital Fund I, II, III, IV and V. Foresite Capital was founded in 2011 by Jim Tananbaum. (wikipedia.org)
  • Foresite Capital is led by Midas List honoree Jim Tananbaum along with managing directors Matt Buten, Alisa Mall, Dorothy Margolskee, Michael Rome, Dennis Ryan, and Vikram Bajaj. (wikipedia.org)
  • Our closing keynote will be given by Jim Tananbaum of Foresite Capital. (harvard.edu)
  • In a blog post Tuesday, Jim Tananbaum, Foresite Capital CEO and managing director, congratulated Mr. Zbar on his new position. (pionline.com)
  • Foresite founder and CEO Jim Tananbaum declined to comment on GenapSys. (structuredfinanceblog.com)
  • Stephen joined Jim Tananbaum in 2011 as the second member of Foresite Capital's investment team. (foresitecapital.com)
  • Foresite Capital Fund V, a $969 million fund, was closed in February 2021. (wikipedia.org)
  • Come meet, interact and network online with more than 1,500 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies at the prestigious Venture Summit Virtual Connect West being held virtually on March 16th-18th, 2021. (advanceventures.com)
  • Greenspring Associates was founded in 2000 to focus solely on venture capital investments. (aetion.com)
  • Greenspring Associates currently manages over $11 billion in committed capital across a variety of specialized venture strategies on behalf of a diverse group of global investors. (aetion.com)
  • Branson and Anne Wojcicki, CEO and cofounder of 23andMe, are each investing $25 million in the PIPE and are joined by institutional investors, including funds managed by Fidelity Management & Research Company LLC, Altimeter Capital, Casdin Capital and Foresite Capital. (mediapost.com)
  • The PIPE investors include Fidelity, Foresite Capital, Altimeter Capital, and Sir Richard Branson , founder of Virgin Group. (marketrealist.com)
  • In 2019, Andrew was named an American Lawyer "Litigator of the Week" twice for both his trial win in Delaware on behalf of Channel Medsystems in Channel's litigation to enforce a $275 million merger agreement and for his win on summary judgment on behalf of Citco Group less than two weeks before trial in a $200 million public pension fund investor suit in Louisiana. (paulweiss.com)
  • Additional new investors include RA Capital Management, funds and accounts advised by T. Rowe Price Associates, Inc., Rock Springs Capital Management LP, Cormorant Asset Management LLC, Cowen Private Investments and Foresite Capital. (fenwick.com)
  • Surveyor (a Citadel company) joined the Series B syndicate alongside existing investors Foresite Capital, Atlas Venture, The Column Group, Arch Venture Partners, Alexandria Venture Investments, and Casdin Capital. (salesandmarketingnetwork.com)
  • Flare Capital raised one of the health care industry's largest dedicated venture capital funds focused exclusively on early stage and emerging growth investments in healthcare technology innovation and is privileged to closely partner with founders and management. (aetion.com)
  • Prior to focusing exclusively on venture capital fund formation and operations, Christi represented funds in their investments in public and private companies, and advised emerging growth companies on formation, structuring, governance matters, strategic and financing transactions, mergers and acquisitions, and public offerings. (gunder.com)
  • Additional investors included Fidelity Management and Research Company, Janus Capital Management, Foresite Capital, Sectoral Asset Management, EcoR1 Capital and founding investors Atlas Venture and Novartis. (thehealthcareinvestor.com)
  • In addition to his investment responsibilities, Stephen has overseen the development of Foresite Capital's investment analyst group and the establishment of Foresite's initial proprietary investment systems. (foresitecapital.com)
  • Foresite Capital funded 10x Genomics since its Series A round in November 2013 and led its Series B round in January 2015, as well as its Series C round in March 2016. (wikipedia.org)
  • NEW YORK (GenomeWeb) - Gene editing technology company Inscripta said today that it that its existing investors have agreed to contribute an additional $20 million to its previously announced Series C funding round , bringing the total raised in the round to $105.5 million. (genomeweb.com)
  • L Catterton and Apax Digital led the round, with participation from existing investor Temasek. (mercomcapital.com)
  • With the support of our new and existing investors, we will continue on our path to address disease drivers at their origin," said Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix Therapeutics. (salesandmarketingnetwork.com)
  • The backing of both our existing and new investors will enable us to fast track development, testing and delivery of our highly parallel desktop platform, which will be available to every researcher to accelerate their ability to use biology on a scale not possible with existing approaches. (rtf.vc)
  • A group of healthcare investors including existing Peak Bio stockholders and Palo Alto Investors have committed to participate in the transaction through a $25 million common stock PIPE at a purchase price of $10.00 per share. (cbinsights.com)
  • With the support of our new and existing investors, we believe that Kriya is well positioned to deliver transformative improvements in cost, scale and efficiency that will help the gene therapy field achieve its full potential across a range of therapeutic areas. (patientsquarecapital.com)
  • Foresite Capital, San Francisco-based healthcare and life sciences investment firm, closed $969M for its fifth flagship fund using Digify. (digify.com)
  • Return backer Highland Capital Partners also contributed. (exitsandoutcomes.com)
  • This investment brings the total capital raised by the company to over $250 million to date, which includes a Series C round led by Highland Capital Partners earlier this year. (femtechinsider.com)
  • Ben, as a seed investor, brings more institutional rigor to the process of investing. (vator.tv)
  • RA Capital led the round as a new investor and was joined by a top-tier mix of new and prior investors such as Farallon Capital Management, Foresite Capital, Franklin Templeton, LLC, Fred Alger Management, New Leaf Venture Partners, Quilvest, and three additional large top-tier institutional investors that were in the last round. (nlvpartners.com)
  • Prior to joining the Corporation, she was a director in the Equity Capital Markets group at Tishman Speyer, working with institutional and private investors in connection with its real estate funds. (bronfman.org)
  • Alisa also currently serves on the PREA Institutional Investor Council and the Advisory Board Declaration Partners, a family office. (bronfman.org)
  • Palo Alto Investors is an SEC-registered investment advisor providing money management services to institutional clients and high net worth individuals. (cbinsights.com)
  • New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. (aetion.com)
  • Prior to joining Foresite Capital, Stephen spent four years as an equity analyst for Palo Alto Investors, a fundamental, long/short equity hedge fund focused on small and micro-cap growth stocks. (foresitecapital.com)
  • Esfandyarpour, who did not respond to multiple attempts to contact him by telephone and LinkedIn, continues to fight GenapSys investor and prominent Bay Area biotech venture capital firm Foresite Capital, which charged in a 2020 civil suit against Esfandyarpour and GenapSys that Foresite was fraudulently induced to pony up $50 million the year before. (structuredfinanceblog.com)
  • He is one of the original investors and drivers of Insitro, an AI company that seeks to become a full service therapeutic engine. (harvard.edu)
  • Tiger Global led and return backers General Catalyst, Drive Capital and Silicon Valley Bank chipped in with a little help from new investors GV, Sequoia Capital Global Equities, Dragoneer Investment Group, and Transformation Capital Partners. (exitsandoutcomes.com)
  • A select group of more than 100 Top Innovators from the Technology, Life Sciences/Healthcare, CleanTech and Fintech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners. (advanceventures.com)
  • In the end, GenapSys was sold in September in U.S. Bankruptcy Court in Delaware for about $42 million to a group of late-stage investors led by San Francisco-based Farallon Capital Management LLC. (structuredfinanceblog.com)
  • With that much money being poured in, there's going to be a need for larger and larger funds to invest that kind of capital, and funds dedicated directly to healthtech companies. (vator.tv)
  • Foresite Capital has raised a total of $968.8 million across two funds, Foresite Capital Fund V and Foresite Capital Opportunity Fund V . The oversubscribed funds closed at their hard-caps with Foresite Capital Fund V raising $775 million and Foresite Capital Opportunity Fund V raising $193.8 million. (privateequityinternational.com)
  • Trusted legal and strategic advisor to venture capital funds. (gunder.com)
  • Christi's fund practice focuses on the formation, organization and operation of venture capital funds and their management entities. (gunder.com)
  • and compliance with securities laws and other regulations applicable to venture capital funds. (gunder.com)
  • We're excited to welcome Foresite Capital, one of the world's leading life-sciences investors, to support this Company to achieve the next stage of its growth and look forward to working closely with this talented team. (rtf.vc)
  • As an early investor, I have seen 23andMe develop into a company with enormous growth potential," Branson stated. (mediapost.com)
  • After the transaction closes, VGAC investors and sponsors will own 13 percent of 23andMe, while PIPE (private investment in public equity) investors will own 6 percent. (marketrealist.com)
  • At almost 44 percent below its 52-week high, the stock offers investors exposure to 23andMe at a bargain. (marketrealist.com)
  • The filing included transcripts of various interviews that the company conducted last week with the press, in case the Q&As prove helpful to potential investors. (exitsandoutcomes.com)
  • The funding round most people emailed me about this past week was keto diet-powered diabetes (and other conditions) reversal company Virta Health 's $65 million Series D, which Sequoia Capital Global Equities led. (exitsandoutcomes.com)
  • We are pleased to expand our syndicate of world-class healthcare investors during this exciting time of growth for the company. (kinnate.com)
  • The Company has raised $30 million USD (£23 million GBP) in this round, which was led by new investor Foresite Capital. (rtf.vc)
  • Venture capital and private equity firms, trusts and foundations pumped at least $230 million into his company, Redwood City-based GenapSys Inc., over nearly a dozen years. (structuredfinanceblog.com)
  • What investors got in return was a limited launch of the company's gene sequencer, a scuttled blank-check merger and more than two years of litigation -- four cases over three courts in two states -- that some company officials said straitjacketed GenapSys as it attempted to raise more cash. (structuredfinanceblog.com)
  • Search company, investor. (cbinsights.com)
  • This partnership with additional world-class investors enables us to build a transformative, multi-generational digital health company that puts people first - where they belong. (femtechinsider.com)
  • HealthQuest Capital focuses on value optimization in healthcare, Dr. Garheng Kong , Founder and Managing Partner at HealthQuest Capital, told me. (vator.tv)
  • In addition to his work with Foresite Capital, Stephen is a Co-Founder and Board Member of Yuwa, an India-based non-profit organization. (foresitecapital.com)
  • The founder and CEO of the venture capital firm, which has backed fast-moving companies at the intersection of tech and biotech, talks about its fifth fund, SPACs and the wealth of cycle-experienced entrepreneurs. (thepowerinvestmentteam.com)
  • Patient Square Capital is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. (patientsquarecapital.com)
  • Flare Capital Partners is a team of proven healthcare technology venture capital investors known for their unparalleled strategic industry resources, insight and total commitment to the success of its entrepreneurs. (aetion.com)
  • The Recruitment and Remuneration Committee is comprised of four members: June Lee (Chair), Corinna zur Bonsen-Thomas, Truffle Capital (represented by Philippe Pouletty) and Sofinnova Partners (represented by Kinam Hong). (life-sciences-usa.com)
  • Headquartered in San Diego, the Kinnate team is composed of drug discovery experts supported by world-class scientific advisors and investors. (kinnate.com)
  • Foresite Capital raised its $100 million Fund I in 2013. (wikipedia.org)
  • In 2014, Foresite Capital closed Foresite Capital Fund II, a $300 million fund. (wikipedia.org)
  • Foresite Capital Fund III, a $450 million fund, was closed in July 2015. (wikipedia.org)
  • Foresite Capital Fund IV, a $668 million fund, closed in March 2018. (wikipedia.org)
  • The additional capital brings the total raised in the round to more than $430 million, which the firm will use to advance its pipeline. (zoominfo.com)
  • In December, the same investors contributed an additional $30 million to the round, bringing the total to $85.5 million. (genomeweb.com)
  • The same investors have now contributed the additional $20 million, Inscripta said. (genomeweb.com)
  • On Wednesday, growth capital firm HealthQuest Capital announced the close of its third fund, HealthQuest Capital Fund III, which was oversubscribed at $440 million. (vator.tv)
  • With this latest fund raise, the San Francisco-based firm now has more than $785 million in capital under management. (vator.tv)
  • That year, it raised $22 million in a series A funding round led by Foresite Capital. (precisionmedicineonline.com)
  • The funding is the biggest-ever round raised by DNAnexus, which prior to this had raised about $127 million with other investors, including Microsoft and Felicis, according to PitchBook data. (automatic.pk)
  • The new capital will be used primarily to advance the company's three lead development programs to key clinical milestones and to establish internal GMP manufacturing capabilities. (fenwick.com)
  • With more than $20 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and health care companies at all stages in a company's lifecycle, from seed stage through IPO. (aetion.com)
  • However, because of non-response or resistance mutations, many fail to benefit from these potentially life-saving medicines," said Peter Kolchinsky, PhD, managing partner at RA Capital Management. (kinnate.com)
  • Concurrent with the financing, Jim Momtazee, Managing Partner of Patient Square Capital, will join Kriya's Board of Directors. (patientsquarecapital.com)
  • The move will provide the financial capital to fund additional investment in growth initiatives across 23andMe's consumer health and therapeutics businesses. (mediapost.com)
  • Stephen Peterson is a Director at Foresite Capital responsible for identifying, evaluating, and executing investment opportunities. (foresitecapital.com)
  • List of startup investors in the FinTech industry, along with their Twitter, LinkedIn, and email addresses. (failory.com)
  • Foresite Capital is an American venture capital and growth equity firm headquartered in San Francisco. (wikipedia.org)
  • Mr. Zbar had been a managing director at health-care and life science private equity firm Foresite Capital. (pionline.com)
  • HealthQuest Capital calls itself a "growth capital firm," and what that really means is that it is investing in companies that are a bit further along in the cycle, meaning they've achieved some measure of commercialization and have proven their thesis. (vator.tv)
  • Lakestar is a global venture capital firm, investing in internet and technology companies worldwide, with offices in London, Berlin, Zurich and New York. (aetion.com)
  • Bob was the founding partner and is now Chairman Emeritus of Gunderson Dettmer, a leading international law firm representing emerging growth companies and venture capital and growth equity investors. (foresitecapital.com)
  • We expect this product to be welcomed by patients, physicians, and importantly payors who desperately need new ways to overcome the huge financial burden associated with diabetes," said Peter Kolchinsky, Managing Director of RA Capital, and one of the key new investors in Intarcia. (nlvpartners.com)
  • Bob represented parties to many of the most significant emerging-growth and venture capital transactions (financings, IPOs, M&A and fund formations) over the last four decades. (foresitecapital.com)
  • That such a large financing was done in the private markets demonstrates that form follows substance and that knowledgeable investors will support a strong team with great data and the right plan to whatever extent it needs via whatever financing structure is appropriate regardless of the general market conditions. (nlvpartners.com)
  • With locations in Silicon Valley, Calif., and Research Triangle Park, N.C., Kriya was founded by pioneers in the biopharmaceutical industry and is backed by blue-chip life sciences and technology investors. (zoominfo.com)
  • We are delighted to be supported by leading life sciences investors who share our vision. (enlightenbio.com)